NCT01188499 2016-05-30
Dose Escalation, Combination Chemotherapy Safety Study of Birinapant (TL32711), in Subjects With Advanced or Metastatic Solid Tumors
TetraLogic Pharmaceuticals
Phase 1/2 Completed
TetraLogic Pharmaceuticals
TetraLogic Pharmaceuticals